Shares of Merck and Pfizer are way down from their previous peaks. Merck's lead drug, Keytruda, grew sales by 19% last year, but its era of patent-protected exclusivity is approaching its end.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Merck & Co has said building its cardiovascular medicines business is central to its strategy to manage the loss of patent protection of cancer juggernaut Keytruda in five years, and new studies ...

After hours: 7:59:57 p.m. EST Loading Chart for MRK ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Les pompiers sont intervenus ce jeudi matin sur le site de Safran Landing System, à Molsheim. En cause, un dégagement de fumée au niveau d'un caniveau. Il s'agissait d'une réaction chimique ...

Vous avez choisi de refuser le dépôt de cookies, vous pouvez à tout moment modifier votre choix, ici. Le contenu de ce site est le fruit du travail de journalistes qui vous apportent chaque ...